Press Releases

BREA, Calif., Jan. 9, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the J.P. Morgan Healthcare Conference on January 15, 2020 in San Francisco, CA. Amir Aghdaei, President and Chief Executive Officer, will represent the com

BIDDEFORD, Maine, Jan. 9, 2020 /PRNewswire/ -- SaVida Health, a leader in outpatient, medication-assisted treatment for opioid and alcohol addiction, opened a new treatment center in Biddeford, ME in December 2019.

NORTH CHICAGO, Ill., Jan. 9, 2020 /PRNewswire/ -- AbbVie issued the following forms today.IRISH TAKEOVER PANEL

FORT LAUDERDALE, Fla., Jan. 9, 2020 /PRNewswire/ -- Led by highly acclaimed physician Dr. Lee Mandel, South Florida Sinus and Allergy Center provides South Florida residents with high-quality

NASHVILLE, Tenn., Jan. 9, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced preliminary revenue for the twelve and three-month periods ended December 31, 2019, based upon preliminary unaudited f

FRANKLIN LAKES, N.J., Jan. 9, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2020 earnings conference call on Thursday, February 6, 2020, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter

NEW YORK, Jan. 9, 2020 /PRNewswire/ -- CHP Merger Corp. (Nasdaq: CHPMU) (the "Company") announced that, commencing January 10, 2020, holders of the units sold in the Company's initial public offering of 30,000,000 units, completed on November 26, 2019, may elect to separately trade the shares of Class A com

SCOTTSDALE, Ariz., Jan. 9, 2020 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE:HTA or the "Company"), announced today that its Board of Directors has appointed Mr. H. Lee Cooper and Mr. Jay P. Leupp as new Independent Directors of the Company. In addition, the Company announced the resignation of

SOUTH SAN FRANCISCO, Calif., Jan. 9, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced preliminary unaudited Andexxa global net revenues for the fourth quarter and full year 2019. For the fourth quarter, the Company expects Andexxa global net revenues to be approximately $28 million. For the fu

SEATTLE, Jan. 9, 2020 /PRNewswire/ -- Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announced the appointment of Adrian Adams as Chairman of the Bo